ORTHOPEDIATRICS CORP (KIDS) Fundamental Analysis & Valuation

NASDAQ:KIDS • US68752L1008

Current stock price

17.31 USD
-0.23 (-1.31%)
At close:
17.31 USD
0 (0%)
After Hours:

This KIDS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. KIDS Profitability Analysis

1.1 Basic Checks

  • KIDS had negative earnings in the past year.
  • In the past year KIDS has reported a negative cash flow from operations.
  • KIDS had negative earnings in 4 of the past 5 years.
  • KIDS had a negative operating cash flow in each of the past 5 years.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

  • KIDS has a better Return On Assets (-9.24%) than 61.41% of its industry peers.
  • Looking at the Return On Equity, with a value of -13.06%, KIDS is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
Industry RankSector Rank
ROA -9.24%
ROE -13.06%
ROIC N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 71.73%, KIDS belongs to the top of the industry, outperforming 82.07% of the companies in the same industry.
  • KIDS's Gross Margin has been stable in the last couple of years.
  • KIDS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

5

2. KIDS Health Analysis

2.1 Basic Checks

  • KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • KIDS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • KIDS has an Altman-Z score of 1.82. This is not the best score and indicates that KIDS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • KIDS has a Altman-Z score (1.82) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.28 indicates that KIDS is not too dependend on debt financing.
  • The Debt to Equity ratio of KIDS (0.28) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACCN/A
WACC10.03%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 7.40 indicates that KIDS has no problem at all paying its short term obligations.
  • The Current ratio of KIDS (7.40) is better than 87.50% of its industry peers.
  • KIDS has a Quick Ratio of 3.52. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
  • KIDS has a better Quick ratio (3.52) than 69.02% of its industry peers.
Industry RankSector Rank
Current Ratio 7.4
Quick Ratio 3.52
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. KIDS Growth Analysis

3.1 Past

  • KIDS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.68%.
EPS 1Y (TTM)-3.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.02% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 11.85% on average over the next years. This is quite good.
EPS Next Y31.26%
EPS Next 2Y24.33%
EPS Next 3Y5.47%
EPS Next 5Y18.02%
Revenue Next Year12.62%
Revenue Next 2Y12.24%
Revenue Next 3Y12.09%
Revenue Next 5Y11.85%

3.3 Evolution

KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5

0

4. KIDS Valuation Analysis

4.1 Price/Earnings Ratio

  • KIDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KIDS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.33%
EPS Next 3Y5.47%

0

5. KIDS Dividend Analysis

5.1 Amount

  • No dividends for KIDS!.
Industry RankSector Rank
Dividend Yield 0%

KIDS Fundamentals: All Metrics, Ratios and Statistics

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (3/13/2026, 8:00:02 PM)

After market: 17.31 0 (0%)

17.31

-0.23 (-1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners68.02%
Inst Owner Change2.81%
Ins Owners5.07%
Ins Owner Change0.03%
Market Cap434.31M
Revenue(TTM)N/A
Net Income(TTM)-45.61M
Analysts82.67
Price Target24.48 (41.42%)
Short Float %5.52%
Short Ratio6.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.35%
Min EPS beat(2)-89.58%
Max EPS beat(2)2.89%
EPS beat(4)1
Avg EPS beat(4)-50.67%
Min EPS beat(4)-115.9%
Max EPS beat(4)2.89%
EPS beat(8)3
Avg EPS beat(8)-27.23%
EPS beat(12)6
Avg EPS beat(12)-15.09%
EPS beat(16)9
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-3.13%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-2.47%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.82%
Revenue beat(16)4
Avg Revenue beat(16)-1.04%
PT rev (1m)0%
PT rev (3m)-0.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 2.61
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS9.06
BVpS13.92
TBVpS6.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.24%
ROE -13.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.73%
FCFM N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.39%
Cap/Sales 6.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.4
Quick Ratio 3.52
Altman-Z 1.82
F-Score3
WACC10.03%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.68%
EPS Next Y31.26%
EPS Next 2Y24.33%
EPS Next 3Y5.47%
EPS Next 5Y18.02%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.97%
Revenue Next Year12.62%
Revenue Next 2Y12.24%
Revenue Next 3Y12.09%
Revenue Next 5Y11.85%
EBIT growth 1Y-10.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year158.21%
EBIT Next 3Y49.16%
EBIT Next 5Y32.7%
FCF growth 1Y86.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.73%
OCF growth 3YN/A
OCF growth 5YN/A

ORTHOPEDIATRICS CORP / KIDS Fundamental Analysis FAQ

What is the fundamental rating for KIDS stock?

ChartMill assigns a fundamental rating of 2 / 10 to KIDS.


Can you provide the valuation status for ORTHOPEDIATRICS CORP?

ChartMill assigns a valuation rating of 0 / 10 to ORTHOPEDIATRICS CORP (KIDS). This can be considered as Overvalued.


What is the profitability of KIDS stock?

ORTHOPEDIATRICS CORP (KIDS) has a profitability rating of 2 / 10.


How financially healthy is ORTHOPEDIATRICS CORP?

The financial health rating of ORTHOPEDIATRICS CORP (KIDS) is 5 / 10.


Is the dividend of ORTHOPEDIATRICS CORP sustainable?

The dividend rating of ORTHOPEDIATRICS CORP (KIDS) is 0 / 10 and the dividend payout ratio is 0%.